Cargando…
In silico targeting SARS-CoV-2 spike protein and main protease by biochemical compounds
Since there is no general agreement on drug treatment of SARS-CoV-2, the search for a new drug capable of treating COVID-19 is of utmost priority. This study aims to dereplicate the chemical compounds of the methanol extract of Salvia officinalis and Artemisia dracunculus, and assay the inhibitory e...
Autores principales: | Babaeekhou, Laleh, Ghane, Maryam, Abbas-Mohammadi, Mahdi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456686/ https://www.ncbi.nlm.nih.gov/pubmed/34565804 http://dx.doi.org/10.1007/s11756-021-00881-z |
Ejemplares similares
-
In silico investigation of potential inhibitors to main protease and spike protein of SARS-CoV-2 in propolis
por: Harisna, Azza Hanif, et al.
Publicado: (2021) -
In silico Screening of Natural Compounds as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike RBD: Targets for COVID-19
por: Teli, Divya M., et al.
Publicado: (2021) -
Hepatitis C virus in Iran; transmission routes, growth in 3a genotype distribution, and lack of liver marker relation with genotypes
por: Rezaee, Nastaran, et al.
Publicado: (2020) -
Antibiotic resistance pattern of Acinetobacter baumannii from burns patients: increase in prevalence of bla(OXA-24-like) and bla(OXA-58-like) genes
por: Tafreshi, Niloofar, et al.
Publicado: (2019) -
Antibiofilm Activity of Kefir Probiotic Lactobacilli Against Uropathogenic Escherichia coli (UPEC)
por: Ghane, Maryam, et al.
Publicado: (2020)